Office of Research Message from the Vice Deans of Research Leadership & Staff Clinical Trials Administration Research Support & Development Biostatistical Resources Grant Support & Review Services NIH K and F Submissions Guide Training Grant Support NIH Resubmission Program NIH Resources NIH Boot Camp Physician Scientist Resources Guidance for Proposal Submissions Grant Incentive Programs and Pilot Awards Researcher Pipeline Policies and Guidelines Environmental Health and Safety Human Research Foreign Affiliations School Center Guidelines Space Allocation Vendor Event Policy Responsible Conduct of Research Rigor and Responsibility COVID-19 Response Funding Opportunities School of Medicine Funding Search Tool School of Medicine Funding Search Tool Home Research Office of Research School of Medicine Funding Search Tool Below is a curated, searchable and filterable list of funding opportunities announced by NIH in their weekly NIH guide LISTSERV. This list reflects funding opportunities pertinent to many UCI researchers. Using filters may reduce your results, so use judiciously. Opportunities are added weekly. You can sign up for the NIH guide listserv to receive a comprehensive list of funding opportunities every Friday. NIH Guide Listserv Search Funding Discipline - Any -Acute/Chronic PainAgingAlcoholism, Alcohol UseAlzheimer's/DementiaAmyotrophic lateral sclerosis (ALS)Artificial Intelligence/Machine LearningAutoimmune/ImmunologyBehavioral and Social ScienceBiomedical ImagingBiomedical TechnologyBrain DisordersCancerCancer GenomicsCannabinoid/CannabidiodCardiology/VascularCaregiving ResearchChronic ConditionsClimate ChangeClinical TrialsClinical/DiagnosticCoronaviruses/COVIDData Science/Software/DatabasesDiabetesDigestive/KidneyDissemination and Implementation ResearchDown SyndromeEarly career research awardEating DisordersEmergency CareEnvironmental healthEpilepsyEye Disease and Disorders of VisionFood AllergiesGene TherapyGenetic TestingGynecologyHealth Disparities/Social determinantsHealthcare deliveryHearing LossHematologyHIV/AIDSHuman GenomeHuntington's DiseaseInfectious Diseases/MicrobiologyLung/RespiratoryMedical EducationMental Health/IllnessMicrobiomeMusculoskeletal/SkinN/ANeurology/NeurodegenerativenoneNutritionObesityOrthopedicOtolaryngology-Head & Neck SurgeryPathologyPatient Care/SafetyPediatricPhysical ActivityPhysical RehabilitationPneumonia & InfluenzaPost-Traumatic Stress Disorder (PTSD)Precision MedicinePregnancy/Maternal Health/ObstetricsRadiation OncologyRare DiseasesRegenerative MedicineSepsisSickle Cell DiseaseSleepSpinal Cord InjuryStem Cell ResearchStrokeSubstance Abuse/AddictionSuicideSurgeryTelehealthTransplantationTraumatic Brain Injury (TBI)UrologyVaccine RelatedVector-Borne DiseasesViolenceWomenWound Healing and Care Date Range Min Max 2024 Deadline 2: May 25, 2024 NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (PAR-23-282) The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. National Institutes of Health (NIH) Federal Infectious Diseases/Microbiology 2024 Deadline 2: May 25, 2024 NHLBI Program Project Applications (P01 Clinical Trials Optional) (PAR-24-065) This Notice of Funding Opportunity (NOFO), issued by the National Heart, Lung, and Blood Institute (NHLBI) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Programs may also include implementation science, health disparities, and translation research that addresses the mission of the Institute. Each application submitted in response to this NOFO must include at least three related research projects that share a common central theme, focus, and/or overall objective. Higher budgets may be requested for applications that include at least four projects, one of which includes an Early Stage Investigator as Project Leader. National Institutes of Health (NIH) Federal Cardiology/Vascular Lung/Respiratory Sleep Deadline: May 25, 2024 AHRQ Health Services Research Demonstration and Dissemination Grants (R18) (PA-24-156) The purpose of this Notice of Funding Opportunity (NOFO) is to seek health services research grant applications focused on AHRQ research priorities, including improving healthcare quality and patient safety, improving healthcare delivery and practice improvement, and enhancing whole-person healthcare delivery. National Institutes of Health (NIH) Federal Healthcare delivery 2024 Deadline 2: May 29, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) (PAR-24-075) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this notice of funding opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award 2024 Deadline 2: May 29, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) (PAR-24-076) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award 2024 Deadline 1: May 29, 2024 Translational Neural Devices (R61/R33 - Clinical Trial Optional) (PAR-24-151) The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Clinical/Diagnostic 2024 Deadline: Jun 03, 2024 Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-23-016) Funding Disciplines: Rare Diseases, Clinical Trials This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. National Institutes of Health (NIH) Federal Rare Diseases Clinical Trials 2024 Deadline 2: Jun 05, 2024 Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) (PAR-23-153) This notice of funding opportunity (NOFO) aims to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects National Institutes of Health (NIH) Federal Cancer Climate Change Healthcare delivery 2024 Deadline 2: Jun 05, 2024 NIH Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) This Funding Opportunity Announcement (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain and the incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical studies. These studies are expected to provide the requisite data needed to advance promising PET ligands for use in clinical research. Projects proposing only preclinical animal studies should consider the companion NOFO (PAR-23-164). National Institutes of Health (NIH) Federal Biomedical Imaging Neurology/Neurodegenerative 2024 Due Date 2: Jun 05, 2024 Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) (PAR-23-168) The overarching goal of this Notice of Funding Opportunity (NOFO) is to support the development and validation of screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a “hit” is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays. National Institutes of Health (NIH) Federal Brain Disorders Mental Health/Illness Neurology/Neurodegenerative Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page ›› Last page Last »
2024 Deadline 2: May 25, 2024 NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (PAR-23-282) The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. National Institutes of Health (NIH) Federal Infectious Diseases/Microbiology
2024 Deadline 2: May 25, 2024 NHLBI Program Project Applications (P01 Clinical Trials Optional) (PAR-24-065) This Notice of Funding Opportunity (NOFO), issued by the National Heart, Lung, and Blood Institute (NHLBI) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Programs may also include implementation science, health disparities, and translation research that addresses the mission of the Institute. Each application submitted in response to this NOFO must include at least three related research projects that share a common central theme, focus, and/or overall objective. Higher budgets may be requested for applications that include at least four projects, one of which includes an Early Stage Investigator as Project Leader. National Institutes of Health (NIH) Federal Cardiology/Vascular Lung/Respiratory Sleep
Deadline: May 25, 2024 AHRQ Health Services Research Demonstration and Dissemination Grants (R18) (PA-24-156) The purpose of this Notice of Funding Opportunity (NOFO) is to seek health services research grant applications focused on AHRQ research priorities, including improving healthcare quality and patient safety, improving healthcare delivery and practice improvement, and enhancing whole-person healthcare delivery. National Institutes of Health (NIH) Federal Healthcare delivery
2024 Deadline 2: May 29, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) (PAR-24-075) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this notice of funding opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award
2024 Deadline 2: May 29, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) (PAR-24-076) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award
2024 Deadline 1: May 29, 2024 Translational Neural Devices (R61/R33 - Clinical Trial Optional) (PAR-24-151) The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Clinical/Diagnostic
2024 Deadline: Jun 03, 2024 Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-23-016) Funding Disciplines: Rare Diseases, Clinical Trials This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. National Institutes of Health (NIH) Federal Rare Diseases Clinical Trials
2024 Deadline 2: Jun 05, 2024 Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) (PAR-23-153) This notice of funding opportunity (NOFO) aims to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects National Institutes of Health (NIH) Federal Cancer Climate Change Healthcare delivery
2024 Deadline 2: Jun 05, 2024 NIH Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) This Funding Opportunity Announcement (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain and the incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical studies. These studies are expected to provide the requisite data needed to advance promising PET ligands for use in clinical research. Projects proposing only preclinical animal studies should consider the companion NOFO (PAR-23-164). National Institutes of Health (NIH) Federal Biomedical Imaging Neurology/Neurodegenerative
2024 Due Date 2: Jun 05, 2024 Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) (PAR-23-168) The overarching goal of this Notice of Funding Opportunity (NOFO) is to support the development and validation of screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a “hit” is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays. National Institutes of Health (NIH) Federal Brain Disorders Mental Health/Illness Neurology/Neurodegenerative